indiaqualityaudits.com

What It Is

India Quality Assurance Audits（IQA） provides quality assurance audit services across India and Asia for pharmaceutical, biotechnology, and IVD companies. The website specifically states that it can conduct GMP, GLP, or GCP audits, covering targets such as GMP CMOs, contract testing laboratories, raw material suppliers, GLP/GCP CROs, and investigator sites. Its parent company is RDW Quality Consulting, LLC, which positions itself as a fully insured, independent quality assurance consulting firm.

Core Capabilities and Enterprise Software Perspective

Based on the collected content, IQA is more of a specialized audit and consulting service than a SaaS or enterprise software product. Its core value lies in access to India-based auditors with 15–20 years of quality assurance experience, supporting multinational companies with compliance reviews across Indian supply chains, outsourced R&D, and clinical-related operations. The website does not disclose any software modules, nor does it mention project management, audit workflows, reporting platforms, third-party integrations, team permissions, APIs, or developer support.

Pricing and Trial

The website does not list standard plans, subscription pricing, or project-based fee structures. It only emphasizes that using local Indian auditors can save up to around 50% of total audit costs, and it offers a Free Consultation. Procurement is therefore more likely to follow a consulting-quote model, where pricing is determined after an initial discussion of the audit scope, location, standards, and deliverables.

Pros and Cons

Its strengths are a clear positioning, a focus on GxP quality audits for the life sciences industry, and an emphasis on local experience and cost advantages. For companies that need to audit Indian suppliers, CROs, or research centers, this type of local resource may be more efficient than sending auditors from overseas. The drawbacks are also clear: publicly available information is limited, with little detail on audit methodology, case studies, report formats, compliance qualifications, or service SLAs. As a SaaS evaluation target, it provides no information on cloud deployment, permissions, security, integrations, or APIs.

Best Fit and Access from China

It is suitable for pharmaceutical, biotechnology, and IVD companies that already have Indian supply chains, outsourced testing, CRO partnerships, or clinical research activities, and need support for supplier onboarding, periodic audits, or targeted GMP/GLP/GCP compliance assessments. Access from China cannot be determined from the available text, and payment methods are not disclosed. Chinese companies seeking similar services may also compare SGS, Bureau Veritas, TÜV, DNV, and local life sciences compliance consulting firms.